Rethinking Oncology Trial Strategy: New Approaches for an Evolving Landscape

This week's Fierce Biotech is brought to you by IQVIA Biotech.

Trouble viewing? Click here.

Rethinking Oncology Trial Strategy

2023 global oncology trends and impact

70% of the R&D pipeline is driven by the innovation of biotech companies, creating immense pressure to deliver novel treatments and secure investor funding in a highly complex environment.

Download the insight brief Navigating the Complex Oncology Landscape: Strategies for Clinical Trial Success to learn how global oncology trends are impacting sponsors and how to optimize clinical trial strategy in the following areas:

Early phase oncology trial design and strategy
Platform design trials
Diversity planning in clinical trial protocols

Your milestones. Your needs. Your team.

If you no longer wish to receive communications from IQVIA Biotech, please opt out here.

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.

You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor
New York, NY 10017